These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
55 related items for PubMed ID: 12971855
1. [Effect of losartan and Nitrendipine on fibrinolytic system in patient with essential hypertensim]. Yin P, Wang L, Rong YD. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):556. PubMed ID: 12971855 [No Abstract] [Full Text] [Related]
2. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan. Makris TK, Stavroulakis G, Papadopoulos DP, Krespi P, Hatzizacharias A, Zilidis A, Tsoukala C, Votteas VE. Drugs Exp Clin Res; 2004 Sep; 30(3):125-32. PubMed ID: 15366789 [Abstract] [Full Text] [Related]
5. In vivo effect of losartan on platelet aggregation in patients with hypertension. Akdemir R, Ozhan H, Yazici M, Gunduz H, Duran S, Gurel C, Ozdas S, Uyan C, Basar I, Ulutin T. Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389 [Abstract] [Full Text] [Related]
12. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study. Naritomi H, Fujita T, Ito S, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N. Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050 [Abstract] [Full Text] [Related]
13. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension. Li Y, Liu G, Jiang B, Gao R, Chen L, Su L, Li J. Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176 [Abstract] [Full Text] [Related]
16. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy. Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B. Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679 [Abstract] [Full Text] [Related]
18. Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy. Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Ibsen H, Julius S, Kjeldsen SE. J Hum Hypertens; 2004 Jun; 18(6):375-80. PubMed ID: 15057253 [Abstract] [Full Text] [Related]
20. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. Fogari R, Derosa G, Lazzari P, Zoppi A, Fogari E, Rinaldi A, Mugellini A. Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]